| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fcaffc23e84e1a7269de0d17be11b37 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-50 |
| filingDate |
1975-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1976-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47b72a96bf8e49c6241d85b29f2d65fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1155c3def098484d5de1b5663658663a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db2c47baf1708e1d3ddd65d07095876e |
| publicationDate |
1976-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3994783-A |
| titleOfInvention |
Differential assay of creatine phosphokinase isoenzymes |
| abstract |
A process for the determination of creatine phosphokinase MB-isoenzyme (CPK-MB) level in serum in which CPK is determined before and after MB-activation with 1,4-dimercapto-2,3-dihydroxy butane or 2-mercaptoethanol, preferably in an assay system using the ATP/ADP conversion. The difference in the two values found is due to the CPK-MB present. The invention is of particular utility in the diagnosis and treatment of myocardial damage. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4250255-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4049496-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4260678-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4067775-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5009996-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5009997-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4912033-A |
| priorityDate |
1975-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |